O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells.
Cheng JY, Hung JT, Lin J, Lo FY, Huang JR, Chiou SP, Wang YH, Lin RJ, Wu JC, Yu J, Yu AL.
Cheng JY, et al. Among authors: huang jr.
Front Immunol. 2022 Jan 3;12:791551. doi: 10.3389/fimmu.2021.791551. eCollection 2021.
Front Immunol. 2022.
PMID: 35046949
Free PMC article.